poloxalene has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caetano, W; César, GB; Consolaro, MEL; da Silva, VRS; Damke, E; Damke, GMZF; de Freitas Meirelles, LE; de Oliveira Silva, S; de Souza Bonfim-Mendonça, P; Gonçalves, RS; Hioka, N; Ratti, BA; Souza, RP | 1 |
| Han, Z; Hao, C; Hou, J; Sheng, D; Wei, L; Yang, X; Zhang, L; Zhang, S; Zhao, N; Zhu, B; Zhu, P | 1 |
2 other study(ies) available for poloxalene and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Selective photodynamic effects on cervical cancer cells provided by P123 Pluronic®-based nanoparticles modulating hypericin delivery.
Topics: Anthracenes; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; HeLa Cells; Humans; Micelles; Nanoparticles; Neoplasm Invasiveness; Oxidative Stress; Perylene; Photochemotherapy; Poloxalene; Time Factors; Uterine Cervical Neoplasms | 2020 |
Inhibition of Growth and Metastasis of Colon Cancer by Delivering 5-Fluorouracil-loaded Pluronic P85 Copolymer Micelles.
Topics: AC133 Antigen; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Drug Carriers; Drug Compounding; Drug Liberation; Fluorouracil; Gene Expression; HCT116 Cells; Humans; Injections, Intravenous; Liver Neoplasms; Male; Mice; Mice, Nude; Micelles; Neoplasm Invasiveness; Poloxalene; Receptors, CXCR4; Splenic Vein; Survival Analysis; Xenograft Model Antitumor Assays | 2016 |